AI assistant
Sending…
GENTEX CORP — Director's Dealing 2021
Feb 4, 2021
30893_dirs_2021-02-04_5ce2f724-6cb1-43f8-b2b1-7384390f2d25.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2021-02-01
Reporting Person: Chiodo Matthew (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-01 | Common Stock | M | 5000.00 | $15.69 | Acquired | 38807.00 | Direct |
| 2021-02-01 | Common Stock | S | 5000.00 | $33.0631 | Disposed | 33807.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-01 | Employee Stock Option (Right to buy) | $15.69 | M | 5000.00 | Disposed | 2021-03-31 | Common Stock (5000.00) | Direct |
Footnotes
F1: Column 5 reflects the acquisition of 209 shares under the Gentex Corp. Employee Stock Purchase Plan.
F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F3: This transaction was executed in multiple trades at prices ranging from $32.89 to $33.41. The price reported above reflects the weighted average price.
F4: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19